Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors (rAd-p53)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2010 by Shenzhen SiBiono GeneTech Co.,Ltd.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Shenzhen SiBiono GeneTech Co.,Ltd
ClinicalTrials.gov Identifier:
NCT00902083
First received: May 11, 2009
Last updated: April 6, 2012
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2012
  Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)